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Portulaca oleracea L., belonging to the Portulacaceae family, is commonly known as purslane in English and Ma-Chi-Xian in
Chinese. It is a warm-climate, herbaceous succulent annual plant with a cosmopolitan distribution. It is eaten extensively as a
potherb and added in soups and salads around theMediterranean and tropical Asian countries and has been used as a folkmedicine
in many countries. Diverse compounds have been isolated from Portulaca oleracea, such as flavonoids, alkaloids, polysaccharides,
fatty acids, terpenoids, sterols, proteins vitamins and minerals. Portulaca oleracea possesses a wide spectrum of pharmacological
properties such as neuroprotective, antimicrobial, antidiabetic, antioxidant, anti-inflammatory, antiulcerogenic, and anticancer
activities. However, few molecular mechanisms of action are known. This review provides a summary of phytochemistry and
pharmacological effects of this plant.
1. Introduction
Portulaca oleracea L. is a warm-climate, herbaceous succulent
annual plant with a cosmopolitan distribution belonging to
the Portulacaceae family. It is commonly known as purslane
(USA and Australia), rigla (Egypt), pigweed (England),
pourpier (France), and Ma-Chi-Xian (China) [1]. It is dis-
tributed widely in the tropical and subtropical areas of the
world including many parts of the United States and is eaten
extensively as a potherb and is added to soups and salads
around the Mediterranean and tropical Asian countries [2].
Americans and aborigines of Australia grind the seeds of this
plant into flour for use in mush and bread [3]. Portulaca
oleracea also provides a source of nutritional benefits owing
to its rich omega-3 fatty acids and antioxidant properties [4].
Portulaca oleracea has been used as a folk medicine in
many countries, acting as a febrifuge, antiseptic, vermifuge,
and so forth [5]. It exhibits a wide range of pharmacological
effects, including antibacterial [6], antiulcerogenic [7], anti-
inflammatory [8], antioxidant [9], and wound-healing [10]
properties. It is listed by the World Health Organization
as one of the most used medicinal plants, and it has been
given the term “Global Panacea” [11]. The Chinese folklore
described it as “vegetable for long life” and it has been used for
thousands of years in traditional Chinese Medicine [12, 13]. It
is cold in nature and sour in taste and is used to cool the blood,
stanch bleeding, clear heat, and resolve toxins. The dried
aerial part of this plant is indicated for the treatment of fever,
dysentery, diarrhoea, carbuncle, eczema and hematochezia,
with a recommended dose of 9–15 g [14–16].
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Portulaca oleracea has a high potential to be used as
human and animal food and to be utilized as a pharmaco-
logical agent in medicine. In this paper, phytochemistry and
pharmacological activities of this plant are reviewed and its
potential for further investigation, exploitation, and utiliza-
tion are discussed.
2. Phytochemistry
Many constituents of Portulaca oleracea have been iso-
lated, including flavonoids, alkaloids, fatty acids, terpenoids,
polysaccharides, vitamins, sterols, proteins, and minerals;
these are listed in Table 1 and the chemical structures of the
main compounds are presented in Figure 1.
One of the most effective constituents present in Chinese
Herbal Medicines are flavonoids which are biologically active
and possess a wide range of pharmacological properties such
as antibacterial, antivirus, anti-inflammation, and antioxida-
tion properties. In the Portulaca oleracea plant, the flavonoids
levels vary according to the part of the plant; the highest levels
are present in the root followed by stem and the leaf; and
seven different flavonoids are present in this plant, including
kaempferol, myricetin, luteolin, apigenin, quercetin, genis-
tein, and genistin [17]. However, only kaempferol and api-
genin have been found in ethanolic extracts of leaves and
stems, with the levels in the former being higher [11]. Portula-
canones B–D, three homoisoflavonoids compounds, display
selectively cytotoxic activities against three human cancer cell
lines (SF-268, NCI-H460, and SGC-7901) [18]. Flavonoids are
also widely present in foods such as fruits and vegetables [19].
In addition to flavonoids, another important chemical
found in this plant is alkaloids including dopa, dopamine,
andnoradrenalin.The content of dopamine andnoradrenalin
is higher in leaves compared to stem and seeds. The amount
of dopamine and noradrenalin obtained from leaves varies
according to the solvents used in the extraction process,
suggesting that the levels of these compounds are dependent
on the solvents used during the extraction process [20].
Oleraceins A, B, C, D, and E are cyclodopa alkaloids isolated
from this plant [21] and several analytes such as (3R)-3,5-
bis(3-methoxy-4-hydroxyphenyl)-2,3-dihydro-2(1H)-pyridi-
none and 1,5-dimethyl-6-phenyl-1,2-dihydro-1,2,4-triazin-
3(2H)-one display cytotoxic activities against human cancer
cells [22].
Portulaca oleracea is also an excellent source of omega-
3 fatty acids, which is usually present in oil and fat of fishes
but not normally found in plants. Omega-3 fatty acids play
an important role in the enhancement of immune function
[23] and prevention and treatment of hypertension, coronary
artery disease, cancer, and other inflammatory and autoim-
mune disorders [24]. It includes 𝛼-linolenic acid and linoleic
acid, which are essential for normal growth, health pro-
motion, and disease prevention in humans. Polysaccharides
found in Portulaca oleracea are potential therapeutic agents
for the treatment of diabetes mellitus owing to their mod-
ulation of blood lipids, metabolism, and decrease of blood
glucose. Portulaca oleracea contains monoterpenes such as
portulosides A and B, diterpenes such as portulene, and 𝛽-
amyrin type triterpenoids [1, 25]; in addition, vitamins have
also been isolated from the leaves of this plant. It contains the
highest content of vitamin A which is a natural antioxidant
playing an important role in vision, maintaining healthy
mucus membranes and protecting against lung and oral cav-
ity cancers among green leafy vegetables.This plant also con-
tains ascorbic acid, 𝛼-tocopherol, and B-complex vitamins,
for example, niacin, pyridoxine, and riboflavin [26]. Further-
more it is rich in minerals like phosphorus, manganese, icon,
calcium selenium [3], and the amino acids isoleucine, proline,
leucine, lysine, phenylalanine, methionine, cystine, valine,
threonine, and tyrosine [2]. Many other constituents have
also been isolated from this plant, such as 𝛽-carotene,
glutathione, melatonin, portulacerebroside A, catechol, and
bergapten.
3. Pharmacology
Over the past decades, numerous researchers have investi-
gated the pharmacological activities of Portulaca oleracea.
This review provides a comprehensive summary of the main
pharmacological properties which are presented below.
3.1. Neuroprotective Activity. Administration of Portulaca
oleracea can scavenge free radicals and antagonize rotenone-
induced neurons apoptosis, dopamine depletion, and com-
plex-I inhibition in striatum of rats, suggesting that Portulaca
oleraceamay be a potential neuroprotective candidate against
Parkinson’s disease [23]. The extract of Portulaca oleracea
(EP) protects nerve tissue/cells from hypoxic damage prob-
ably by elevation of glycolysis, EPO, and hypoxia inducible
factor-1 expression levels [27]. The ethanol extract decreases
the activity of caspase-3 in neuron whilst reducing serum
levels of neuron specific enolase in hypoxia mice and the
pathological damages caused by hypoxia. In these studies,
an increase in the neuron viability and an induction in the
mRNA and protein expression of endogenous erythropoietin
have also been reported. Thus, the stabilization of hypoxia
inducible factor-1 𝛼 expression is associated with the neu-
roprotective effects of EP against hypoxia injury by eliciting
endogenous erythropoietin expression [28]. 𝛽-Cyanin evi-
dently inhibits D-galactose-induced neurotoxicity in mice,
which at the doses of 50 and 100mg/kg upregulates the activi-
ties of superoxide dismutases, catalase, glutathione reductase,
and glutathione peroxidase, whilst reducing the level of the
lipid peroxidation product malondialdehyde in the brain of
D-galactose-treated mice. When compared to vitamin C, 𝛽-
cyanin play a more pronounced effect on alleviating cogni-
tion deficits in mice [29]. The total alkaloidal extracts from
31 traditional Chinese Herbal Medicines were tested for their
acetylcholinesterase (AChE) inhibitory activities by Ellman’s
method and modified TLC bioautographic assay. As a result,
the alkaloidal extract ofPortulaca oleracea significantly inhib-
ited AChE activity at a final concentration of 100 𝜇g/mL with
the IC50 value of 29.4 𝜇g/mL.The use of AChE inhibitors has
been a promising treatment strategy for Alzheimer’s disease
(AD); therefore, Portulaca oleraceamay be an effective agent
for the prophylaxis and treatment of AD [30].
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Table 1: Compounds isolated from purslane.
Classification Chemical component Part of plant Reference
Flavonoids
Kaempferol (1) Leaf and stem [11]
Apigenin (2) Leaf and stem [11]
Luteolin (3) Whole plant [11]
Myricetin (4) Whole plant [11]
Quercetin (5) Whole plant [11]
Portulacanones A (6) Aerial part [18]
Portulacanones B (7) Aerial part [18]
Portulacanones C (8) Aerial part [18]
Portulacanones D (9) Aerial part [18]
2,2󸀠-Dihydroxy-4󸀠,6󸀠-dimethoxychalcone (10) Aerial parts [18]
Genistein Whole plant [17]
Genistin Whole plant [17]
Alkaloids
Dopamine (11) Stem, leaf and seed [20]
Noradrenalin (12) Stem, leaf and seed [48]
Dopa [21]
Oleraceins A (13) Whole plant [21]
Oleraceins B (14) Whole plant [21]
Oleraceins C (15) Whole plant [21]
Oleraceins D (16) Whole plant [21]
Oleraceins E (17) Whole plant [21]
Oleracins I Stem [21]
Oleracins II Stem [21]
Adenosine Whole plant [21]
N-trans-Feruloyltyramine (18) Aerial part [22]
(7󸀠R)-N-Feruloylnormetanephrine (19) Aerial part [22]
1,5-Dimethyl-6-phenyl-1,2-dihydro-1,2,4-triazin-3(2H)-one (20) Aerial part [22]
(3R)-3,5-Bis(3-methoxy-4-hydroxyphenyl)-2,3-dihydro-2(1H)-pyridinone (21) Aerial part [22]
Thymine (22) Aerial parts [18]
Uracil (23) Aerial parts [18]
N-cis-Feruloyltyramine (24) Aerial parts [18]
N-trans-Feruloyloctopamine (25) Aerial parts [18]
N-cis-Feruloyloctopamine (26) Aerial parts [18]
Trollisine (27) Aerial part [49]
Aurantiamide (28) Aerial part [49]
Aurantiamide acetate (29) Aerial part [49]
Cyclo(L-tyrosinyl-L-tyrosinyl) (30) Aerial part [49]
1,5-Dimethyl-6-phenyl-1,6,3,4-tetrahydro-1,2,4-2(1H)-triazin (31) Aerial part [49]
Scopoletin [50]
Terpenoids
Portuloside A (32) Aerial part [51]
Portuloside B (33) Aerial part [52]
(3S)-3-O-(𝛽-D-Glucopyranosyl)-3,7-dimethylocta-1,6-dien-3-ol (34) Aerial part [52]
(3S)-3-O-(𝛽-D-Glucopyranosyl)-3,7-dimethylocta-1,5-dien-3,7-diol (35) Aerial part [52]
Portulene (36) Aerial part [1]
Lupeol (37) Aerial part [1]
(2a,3a)-3-{[4-O-(𝛽-D-Glucopyranosyl)-𝛽-D-xylopyranosyl]oxy}-2,23-dihydroxy-30-
methoxy-30-oxoolean-12-en-28-oic acid
(38)
Aerial part [25]
(2a,3a)-2,23,30-Trihydroxy-3-[(𝛽-D-xylopyranosyl)oxy]olean-12-en-28-oic acid (39) Aerial part [25]
Friedelane Aerial part [25]
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Table 1: Continued.
Classification Chemical component Part of plant Reference
Organic
acids
3-Quinolinecarboxylic acid (40) Aerial parts [18]
Indole-3-carboxylic acid (41) Aerial parts [18]
a-Linolenic acid Leaf [24]
Linoleic acid Leaf [26]
Palmitic acid Leaf [4]
Stearic acid Leaf [4]
Oleic acid Leaf [4]
p-Coumaric acid Whole plant [21]
Ferulic acid Whole plant [21]
Docosapentaenoic acid Stem [26]
Eicosapentaenoic acid [53]
Docosahexaenoic acid [53]
Catechol [53]
Caffeic acid Aerial part [54]
Oxalic acid Leaf [2]
Lonchocarpic acid [50]
Vitamins
Vitamin A Leaf [26]
Riboflavin Leaf [26]
Niacin Leaf [26]
Pyridoxine Leaf [26]
Vitamin C Leaf [26]
Folates Leaf [26]
Pantothenic acid Leaf [26]
Thiamin Leaf [26]
𝛼-Tocopherol Leaf [4]
Hesperidin Leaf [55]
Minerals
Phosphorus Root, stem and leaf [3]
Iron Root, stem and leaf [3]
Manganese Root, stem and leaf [3]
Calcium Root, stem and leaf [3]
Copper Root, stem and leaf [3]
Zinc Leaf [26]
Selenium Leaf [26]
Magnesium Leaf [26]
Other
compounds
Portulacerebroside A (42) Aerial part [56]
𝛽-Sitosterol (43) Aerial part [1]
Daucosterol (44) Aerial part [1]
𝛽-Carotene Leaf [4]
Glutathione Leaf [4]
Proline Leaf [57]
Melatonin Leaf [24]
1,4-Di-O-acetyl-2,3,5-tri-O-methyl-L-arabinitol Leaf [58]
1,4,5-Tri-O-acetyl-2,3-di-O-methyl-L-arabinitol Leaf [58]
1,5-Di-O-acetyl-2,3,4,6-tetra-O-methyl-D-galactitol Leaf [58]
1,4,5-Tri-O-acetyl-2,3,6-tri-O-methyl-D-galactitol Leaf [58]
1,3,4,5-Tetra-O-acetyl-2,6-di-O-methyl-D-galactitol Leaf [58]
Chlorophyll [53]
Tannin [53]
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Table 1: Continued.
Classification Chemical component Part of plant Reference
Isopimpinellin [50]
Robustin [50]
Bergapten [50]
3.2. Antidiabetic Activity. Portulaca oleracea attenuates body
weight, serum free fatty acids, and hyperinsulinemia. It
also increases insulin sensitivity and ameliorates impaired
glucose tolerance and lipid metabolism in rats with type
2 diabetes mellitus induced by injection of streptozotocin
(25mg/kg) and feeding of high calorie forage, suggesting that
Portulaca oleracea alleviates insulin resistance [31]. Admin-
istration of the seeds powder (5 g × 2/day) increases high
density lipoprotein cholesterol (HDLC) and albumin, while
lowering the levels of serum total cholesterol, triglycerides,
low density lipoprotein cholesterol (LDLC), liver gamma
glutamyl transaminase (GGT), alanine transaminase (ALT),
aspartate transaminase (AST), total and direct bilirubin,
fasting and postprandial blood glucose, insulin, body weight,
and body mass index in type 2 diabetic subjects. There were
no differences in these results compared to the data obtained
with metformin treatment (1500mg/day) except for LDLC,
HDLC, and alkaline phosphatase (ALP) levels, suggesting
that Portulaca oleracea seeds are valuable and effective as an
adjunctive and alternative therapy for the treatment of type 2
diabetes mellitus [32].
The aqueous extract of Portulaca oleracea also prevents
diabetic vascular inflammation, hyperglycemia, and diabetic
endothelial dysfunction in type 2 diabetic db/db mice,
suggesting its protective role against diabetes and related
vascular complications [33].The crude polysaccharide extract
of this plant also lowers blood glucose and modulates the
metabolism of blood lipids and glucose in alloxan-induced
diabeticmice [34], whilst decreasing the levels of total choles-
terol, triglycerides, and fasting blood glucose in type 2
diabetic mice [32].
3.3. Antioxidant Activity. The antioxidant property of Por-
tulaca oleracea is attributed to its constituents, such as gal-
lotannins, omega-3 fatty acids, ascorbic acid, 𝛼-tocopherols,
kaempferol, quercetin, and apigenin [8, 16, 17].The single cell
gel electrophoresis assay (comet assay), which is an simple,
rapid, and inexpensive method for measuring DNA strand
breaks, confirmed that the aqueous extract significantly
alleviated hydrogen peroxide-induced oxidative DNA lesions
in human lymphocytes, whereas the ethanolic extract had no
effects, which may be associated with the antioxidant con-
stituents contained in the aqueous extract [35]. The aqueous
extract decreases high fat diet-elicited oxidative damage by
modulating blood and liver antioxidant enzyme activities,
elevating leptin/𝛽-actin and liver PPARa/𝛽-actin and inhibit-
ing the protein expression of p-PERK and the FAS mRNA
expression of liver and spleen in mice [9]. In another study,
the aqueous extract at a concentration range of 100, 150, 200,
and 400 𝜇g/mL and the ethanolic extract at a range of 1200
and 1800 𝜇g/mL, respectively, exerted cytoprotective effects
on 2,2󸀠-azobis hydrochloride-induced hemolytic damages of
RBCs in a concentration-dependent manner [36].
3.4. Anticancer Activity. Polysaccharides from Portulaca
oleracea display several biological activities, such as anti-
cancer, antioxidation, anti-inflammation, and immunity
enhancing properties [37–40]. Polysaccharides evidently
scavenge the accumulation of free radicals and modulate
immunity functions of rats with ovarian cancer [41]. Sulfated
derivatives of POP, a water-soluble polysaccharide isolated
from Portulaca oleracea, have a suppressive effect on the
growth of HeLa and HepG2 cells in vitro, suggesting that the
sulfation of POP increases the cytotoxicity in tumor cells [42].
In addition to polysaccharides, other bioactive compounds
such as cerebrosides, homoisoflavonoids, and alkaloids also
show in vitro cytotoxic activities against human cancer cell
lines. Portulacerebroside A stimulates human liver cancer
HCCLM3 cell apoptosis via the activation of the p38 MAPK-
and JNK-triggered mitochondrial death pathway [43] and
2,2󸀠-dihydroxy-4󸀠,6󸀠-dimethoxychalcone is more active
against cell line SGC-7901 with an IC
50
value of 1.6 ug/mL
than mitomycin C which has an IC
50
value of 13.0 ug/mL.
Portulacanones B is active against SGC-7901 cell lines with
an IC
50
value of 16.2 ug/mL, which is very close to the
value obtained with mitomycin C. 2,2󸀠-Dihydroxy-4󸀠,6󸀠-
dimethoxychalcone is moderately active against K-562 cells
with an IC
50
value of 24.6 ug/mL and portulacanones B–D
show selective cytotoxic activity against SF-268 and/or
NCI-H460 cells with IC
50
values of 14.3–20.1 ug/mL [18]. N-
trans-Feruloyltyramine, (7󸀠R)-N-feruloylnormetanephrine,
1,5-dimethyl-6-phenyl-1,2-dihydro-1,2,4-triazin-3(2H)-one,
and (3R)-3,5-bis(3-methoxy-4-hydroxyphenyl)-2,3-dihydro-
2(1H)-pyridinone have weak bioactivities against K562
with IC
50
values of 222.77, 66.94, 90.09, and 41.52 umol/L,
respectively, and moderate bioactivities against A549 with
IC
50
values of 28.80, 21.76, 24.54, and 37.20 umol/L, respec-
tively [22]. These studies demonstrate that Portulaca oleracea
has a potential application in the treatment of cancer.
3.5. Antimicrobial. Portulaca oleracea possesses antibacterial,
antifungal, and antiviral activities as revealed by its antifungal
effect against dermatophytes of the genera Trichophyton [44].
A pectic polysaccharide isolated from the aerial part of this
plant displays antiherpes property against simplex virus type
2 which is due to the inhibition of virus penetration and not
virus adsorption [45]. A 70% methyl alcohol extract of Por-
tulaca oleracea shows antibacterial activity against the Gram-
negative stains: Escherichia coli, Pseudomonas aeruginosa,
and Neisseria gonorrhea with inhibition zones of 14, 15, and
15mm, respectively, and the Gram-positive strains: Staphylo-
coccus aureus, Bacillus subtilis, and Streptococcus faecaliswith
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Figure 1: Chemical structures of main compounds present in Portulaca oleracea.
inhibition zones of 13, 14, and 15mm, respectively, as well as
antifungal activity against Candida albicans with inhibition
zone of 12mm [1].
3.6. Anti-Inflammatory Activity. Pretreatment with the aque-
ous extract of Portulaca oleracea inhibits tumor necrosis
factor- (TNF-) 𝛼-induced production of intracellular reac-
tive oxygen species (ROS) and overexpression of intercel-
lular adhesion molecule- (ICAM-) 1, vascular cell adhesion
molecule (VCAM)-1, and E-selectin in human umbilical vein
endothelial cells (HUVECs) in a dose-dependent manner.
This extract also suppresses the translocation of nuclear
factor 𝜅B (NF-𝜅B) p65 to the nucleus, TNF-𝛼-inducedNF-𝜅B
binding, and the degradation of inhibitor molecule (I𝜅B)𝛼.
Furthermore, an inhibition in the adhesion of HL-60 cells
to TNF-𝛼-induced HUVECs and TNF-𝛼-induced mRNA
expression of interleukin- (IL-) 8 andmonocyte chemoattrac-
tant protein- (MCP-) 1 is also observed. The aqueous extract
of Portulaca oleracea may also play an important role in the
suppression of the vascular inflammatory process related to
the development of atherosclerosis [46].
3.7. Antiulcerogenic Activity. Aqueous and ethanolic extracts
of Portulaca oleracea at 0.8 g/kg and 1.4 g/kg, respectively, can
reduce the severity of HCl-induced gastric ulcers in a dose-
dependent manner; this is comparable to the effect observed
with sucralfate 0.1 g/kg. In addition, the aqueous extract (0.56
and 0.8 g/kg) and the ethanolic extract (0.8 and 1.4 g/kg)
display suppression of lesions induced by absolute ethanol.
The oral and intraperitoneal doses of both extracts dose-
dependently increase the pH of gastric juice in mice with
pylorus ligation.Thus, Portulaca oleracea holds great promise
as an effective therapeutic agent for gastrointestinal diseases
due to its gastroprotective activity [7].
3.8. Hepatoprotective Activity. Intraperitoneal administra-
tion of CCl
4
elicits liver injury in rats, which notably upreg-
ulates the levels of total bilirubin and serum hepatic marker
enzymes, including glutamate pyruvate transaminase (GPT)
and glutamate oxaloacetate transaminase (GOT). A 70%
alcohol extract of Portulaca oleracea significantly reverses the
increase in hepatic marker enzymes and total bilirubin levels,
confirming the hepatoprotective activity of this plant [1].
3.9. Other Activities. The ethanol extract from Portulaca
oleracea at a concentration range of 100, 200, and 400mg/kg,
respectively, displays a dose-dependent effect in prolonging
the survival time of mice in hypoxic models, including closed
normobaric hypoxia and potassiumcyanide or sodiumnitrite
toxicosis.This extract also enhances the activities of phospho-
fructokinase, pyruvate kinase, and lactate dehydrogenase in
glycolysis and the level of adenosine triphosphate of mouse
cortices in hypoxia models [12]. The preliminary wound
healing activity of Portulaca oleracea has been appraised in
Mus musculus JVI-1 and it has been shown that a fresh crude
extract significantly accelerates the wound healing course by
the stimulation of wound contraction and downregulation of
the surface area of the excisionwound [10]. Portulaca oleracea
also has the ability to accumulate Se even at the shortest time
span of 42 days, and hence it can perform the dual functions
of preventing the occurrence of Se deficiency linked diseases
such as Keshan and Kashin-Beck diseases [47].
4. Conclusion
Portulaca oleracea is of considerable importance to the
food industry and also possesses a wide spectrum of phar-
macological properties such as neuroprotective, antimi-
crobial, antidiabetic, antioxidant, anti-inflammatory, antiul-
cerogenic, and anticancer activities, which are associated
with its diverse chemical constituents, including flavonoids,
alkaloids, polysaccharides, fatty acids, terpenoids, sterols,
proteins, vitamins, and minerals.
Although bioactivities of extracts or compounds isolated
from Portulaca oleracea are substantiated by using in vitro
and in vivo studies including animal models and cell culture
studies, the mechanisms of action have not been addressed.
Hence, more mechanistic studies are required before Portu-
laca oleracea can be considered for further clinical use. This
review concludes that Portulaca oleracea is an edible and a
medicinal plant which is important to the food industry and
may also have a significant role to play in health care provided
that adequate studies are conducted.
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